Goldman Sachs’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Sell |
184,112
-86,099
| -32% | -$9.17M | ﹤0.01% | 1789 |
|
|
2025
Q1 | $24.6M | Buy |
270,211
+69,741
| +35% | +$6.35M | ﹤0.01% | 1546 |
|
|
2024
Q4 | $22.8M | Buy |
200,470
+170,126
| +561% | +$19.4M | ﹤0.01% | 1681 |
|
|
2024
Q3 | $3.6M | Sell |
30,344
-101,277
| -77% | -$12M | ﹤0.01% | 2980 |
|
|
2024
Q2 | $10.6M | Sell |
131,621
-30,461
| -19% | -$2.45M | ﹤0.01% | 2047 |
|
|
2024
Q1 | $15M | Sell |
162,082
-20,796
| -11% | -$1.92M | ﹤0.01% | 1745 |
|
|
2023
Q4 | $19.3M | Buy |
182,878
+42,177
| +30% | +$4.45M | ﹤0.01% | 1595 |
|
|
2023
Q3 | $15.3M | Sell |
140,701
-67,030
| -32% | -$7.28M | ﹤0.01% | 1682 |
|
|
2023
Q2 | $22.4M | Sell |
207,731
-98,092
| -32% | -$10.6M | ﹤0.01% | 1468 |
|
|
2023
Q1 | $38.1M | Buy |
305,823
+149,721
| +96% | +$18.7M | 0.01% | 1075 |
|
|
2022
Q4 | $23.4M | Sell |
156,102
-31,699
| -17% | -$4.76M | 0.01% | 1479 |
|
|
2022
Q3 | $25.3M | Sell |
187,801
-32,097
| -15% | -$4.33M | 0.01% | 1425 |
|
|
2022
Q2 | $32.8M | Sell |
219,898
-120,879
| -35% | -$18M | 0.01% | 1255 |
|
|
2022
Q1 | $58.1M | Buy |
340,777
+12,284
| +4% | +$2.1M | 0.01% | 980 |
|
|
2021
Q4 | $84.7M | Buy |
328,493
+95,679
| +41% | +$24.7M | 0.02% | 775 |
|
|
2021
Q3 | $63.6M | Sell |
232,814
-76,722
| -25% | -$20.9M | 0.01% | 934 |
|
|
2021
Q2 | $69.3M | Buy |
309,536
+251,276
| +431% | +$56.3M | 0.02% | 859 |
|
|
2021
Q1 | $6.36M | Buy |
58,260
+20,811
| +56% | +$2.27M | ﹤0.01% | 2501 |
|
|
2020
Q4 | $3.05M | Buy |
37,449
+26,685
| +248% | +$2.18M | ﹤0.01% | 2806 |
|
|
2020
Q3 | $745K | Sell |
10,764
-137,285
| -93% | -$9.5M | ﹤0.01% | 3473 |
|
|
2020
Q2 | $9.88M | Buy |
+148,049
| New | +$9.88M | ﹤0.01% | 1954 |
|